These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 22296959)
1. Ten years of antipsychotic prescribing to children: a Canadian population-based study. Alessi-Severini S; Biscontri RG; Collins DM; Sareen J; Enns MW Can J Psychiatry; 2012 Jan; 57(1):52-8. PubMed ID: 22296959 [TBL] [Abstract][Full Text] [Related]
2. A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011. Ronsley R; Scott D; Warburton WP; Hamdi RD; Louie DC; Davidson J; Panagiotopoulos C Can J Psychiatry; 2013 Jun; 58(6):361-9. PubMed ID: 23768264 [TBL] [Abstract][Full Text] [Related]
3. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011. Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818 [TBL] [Abstract][Full Text] [Related]
4. Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006. Alessi-Severini S; Biscontri RG; Collins DM; Kozyrskyj A; Sareen J; Enns MW Psychiatr Serv; 2008 May; 59(5):547-53. PubMed ID: 18451015 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Young People With Antipsychotic Medications in the United States. Olfson M; King M; Schoenbaum M JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724 [TBL] [Abstract][Full Text] [Related]
7. A review of pharmacoepidemiologic studies of antipsychotic use in children and adolescents. Patten SB; Waheed W; Bresee L Can J Psychiatry; 2012 Dec; 57(12):717-21. PubMed ID: 23228229 [TBL] [Abstract][Full Text] [Related]
8. The Pharmacoepidemiology of Psychotropic Medication Use in Canadian Children from 2012 to 2016. Pringsheim T; Stewart DG; Chan P; Tehrani A; Patten SB J Child Adolesc Psychopharmacol; 2019 Dec; 29(10):740-745. PubMed ID: 31355670 [No Abstract] [Full Text] [Related]
9. Incident users of antipsychotics: who are they and how do they fare? Baandrup L; Kruse M Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):505-12. PubMed ID: 26409887 [TBL] [Abstract][Full Text] [Related]
10. Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups. Lao KSJ; Tam AWY; Wong ICK; Besag FMC; Man KKC; Chui CSL; Chan EW Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1387-1394. PubMed ID: 28665012 [TBL] [Abstract][Full Text] [Related]
11. Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth. Edelsohn GA; Karpov I; Parthasarathy M; Hutchison SL; Castelnovo K; Ghuman J; Schuster JM J Am Acad Child Adolesc Psychiatry; 2017 Jan; 56(1):59-66. PubMed ID: 27993230 [TBL] [Abstract][Full Text] [Related]
12. Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec. Lachaine J; De G; Sikirica V; Van Stralen J; Hodgkins P; Yang H; Heroux J; Ben Amor L Can J Psychiatry; 2014 Nov; 59(11):597-608. PubMed ID: 25565476 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic Medication Prescribing Trends in a Pediatric Population in Northern Poland 2008-2012. Waszak PM; Zagożdżon P; Pierucka M; Kubanek A J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):631-636. PubMed ID: 30048153 [TBL] [Abstract][Full Text] [Related]
14. Average duration of treatment with antipsychotics among concession card holders in Australia. Kjosavik SR; Gillam MH; Roughead EE Aust N Z J Psychiatry; 2017 Jul; 51(7):719-726. PubMed ID: 28195003 [TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications. Burcu M; Zito JM; Ibe A; Safer DJ J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):112-9. PubMed ID: 24690011 [TBL] [Abstract][Full Text] [Related]
16. Regional variation and clinical indicators of antipsychotic use in residential treatment: a four-state comparison. Rawal PH; Lyons JS; MacIntyre JC; Hunter JC J Behav Health Serv Res; 2004; 31(2):178-88. PubMed ID: 15255225 [TBL] [Abstract][Full Text] [Related]
17. Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011. Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):806-813. PubMed ID: 28618239 [TBL] [Abstract][Full Text] [Related]
18. Prescription of methylphenidate to children and youth, 1990-1996. Miller AR; Lalonde CE; McGrail KM; Armstrong RW CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572 [TBL] [Abstract][Full Text] [Related]
19. Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years. Doey T; Handelman K; Seabrook JA; Steele M Can J Psychiatry; 2007 Jun; 52(6):363-8. PubMed ID: 17696022 [TBL] [Abstract][Full Text] [Related]
20. On- and Off-Label Atypical Antipsychotic Prescription Trends Across a Nine-Year Period Among Adolescents Pre- to Post-COVID-19. Costales B; Slama NE; Penfold RB; Nugent JR; Spalding SR; Sterling SA; Iturralde E Acad Pediatr; 2024 Aug; 24(6):995-1000. PubMed ID: 38458489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]